Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04720547 · ClinicalTrials.gov registry record · Phase 4
Sleep and Breathing in the General Population - Chemical Stimuli
A Phase 4 study of Sleep Disordered Breathing, sponsored by Wayne State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT04720547: Completed Phase 4 study of Sleep Disordered Breathing, sponsored by Wayne State University.
NCT04720547 is a Phase 4 study of Sleep Disordered Breathing that has completed, run by Wayne State University. The registered enrollment target is 14 participants, below the 198-participant average among 19 other Sleep Disordered Breathing trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04720547, a Phase 4 study of Sleep Disordered Breathing, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
Central sleep apnea (CSA) is a common condition and its treatment remains elusive. The focus of this proposal is to identify the role of the physiologic path involving cortical arousals in CSA by decreasing arousal frequency using the pharmacological agent zolpidem. The goal is to identify the acute effects of administering zolpidem on sleep and respiratory outcomes, and subsequently, its effect on the severity of CSA and propensity to develop CSA. This study will shed light on the mechanisms underlying CSA that involve cortical arousals and will guide future therapeutic interventions for CSA.
Primary Outcome
The number of central apneas and hypopneas per hour of sleep was obtained from polysomnography studies.
Conditions Studied
Interventions
- DRUG Zolpidem
- OTHER No Treatment
Study Locations (1)
Michigan
- John D. Dingell VA Medical Center - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-07-03 |
| Est. Completion | 2020-02-29 |
| Phase | Phase 4 |
What the finished NCT04720547 record still lists
NCT04720547 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 198-participant average among 19 other Sleep Disordered Breathing trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Sleep Disordered Breathing appearing as the primary indexed condition, and to 2 interventions - of which Zolpidem is the first listed.
NCT04720547 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04720547 about?
NCT04720547 is a clinical study titled "Sleep and Breathing in the General Population - Chemical Stimuli". Central sleep apnea (CSA) is a common condition and its treatment remains elusive. The focus of this proposal is to identify the role of the physiologic path involving cortical arousals in CSA by decreasing arousal frequency using the pharmacological agent zolpidem. The goal is to identify the acute...
What is the current status of trial NCT04720547?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2018-07-03. Estimated completion is 2020-02-29.
What conditions does trial NCT04720547 study?
This clinical trial studies the following conditions: Sleep Disordered Breathing.
What interventions are being tested in trial NCT04720547?
The interventions under investigation include: Zolpidem (DRUG), No Treatment (OTHER).
Who is sponsoring clinical trial NCT04720547?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04720547 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disordered Breathing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04720547's enrollment target sits among peer trials
14 19th of 19 the lowest of 19 other Sleep Disordered Breathing trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Disordered Breathing trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Central Sleep Apnea : Physiologic Mechanisms to Inform Treatment
RECRUITING · Phase 4
-
Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia
RECRUITING · Phase 4
-
Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders
RECRUITING
-
Sleep Disordered Breathing With Opioid Use
RECRUITING · Phase 1
-
Belun Ring Platform With an Improved Algorithm for OSA Assessment
RECRUITING · NA
-
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy